![Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study | BMC Emergency Medicine | Full Text Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study | BMC Emergency Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12873-020-00386-z/MediaObjects/12873_2020_386_Fig1_HTML.png)
Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study | BMC Emergency Medicine | Full Text
![Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding | Circulation Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding | Circulation](https://www.ahajournals.org/cms/asset/eee56cb7-8e2a-4f34-9797-b1ea01fb8716/circulationaha.113.005107.fp.png)
Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding | Circulation
![The benefit of prothrombin complex concentrate in decreasing neurological deterioration in patients with warfarin-associated intracerebral haemorrhage | HKMJ The benefit of prothrombin complex concentrate in decreasing neurological deterioration in patients with warfarin-associated intracerebral haemorrhage | HKMJ](https://www.hkmj.org/system/files/hkmj144246-table1.jpg)
The benefit of prothrombin complex concentrate in decreasing neurological deterioration in patients with warfarin-associated intracerebral haemorrhage | HKMJ
Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models | PLOS ONE
Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
![Comparison of Hemostatic Outcomes in Patients Receiving Fixed-Dose vs. Weight-Based 4-Factor Prothrombin Complex Concentrate - ScienceDirect Comparison of Hemostatic Outcomes in Patients Receiving Fixed-Dose vs. Weight-Based 4-Factor Prothrombin Complex Concentrate - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0736467920303875-gr1.jpg)
Comparison of Hemostatic Outcomes in Patients Receiving Fixed-Dose vs. Weight-Based 4-Factor Prothrombin Complex Concentrate - ScienceDirect
![Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy | European Journal of Hospital Pharmacy Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy | European Journal of Hospital Pharmacy](https://ejhp.bmj.com/content/ejhpharm/28/e1/e66/F1.large.jpg)
Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy | European Journal of Hospital Pharmacy
![PDF] Activated prothrombin complex concentrates for the reversal of anticoagulant-associated coagulopathy. | Semantic Scholar PDF] Activated prothrombin complex concentrates for the reversal of anticoagulant-associated coagulopathy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/80579c3b1fb5e450d3f8900ab88555932a952df1/3-Table1-1.png)
PDF] Activated prothrombin complex concentrates for the reversal of anticoagulant-associated coagulopathy. | Semantic Scholar
Ken Dodd, MD on Twitter: "Fixed-Dosing of 1,500 units of the four-factor prothrombin complex concentrate Kcenta (compared to variable dosing) 1. Effectively corrects INR < 2.0 2. Decreases time to reversal 3.
![High-Dose 4-Factor Prothrombin Complex Concentrate for Warfarin-Induced Intracranial Hemorrhage - Cristian Merchan, Tania Ahuja, Veronica Raco, Ariane Lewis, 2020 High-Dose 4-Factor Prothrombin Complex Concentrate for Warfarin-Induced Intracranial Hemorrhage - Cristian Merchan, Tania Ahuja, Veronica Raco, Ariane Lewis, 2020](https://journals.sagepub.com/cms/10.1177/1941874419844343/asset/images/large/10.1177_1941874419844343-fig1.jpeg)
High-Dose 4-Factor Prothrombin Complex Concentrate for Warfarin-Induced Intracranial Hemorrhage - Cristian Merchan, Tania Ahuja, Veronica Raco, Ariane Lewis, 2020
![Emergency Release of Four-Factor Prothrombin Complex Concentrate (Kcentra®) | McGovern Medical School Emergency Release of Four-Factor Prothrombin Complex Concentrate (Kcentra®) | McGovern Medical School](https://med.uth.edu/surgery/wp-content/uploads/sites/66/2022/03/Bleeding-Prothrombin-Complex-Concentrate.jpg)
Emergency Release of Four-Factor Prothrombin Complex Concentrate (Kcentra®) | McGovern Medical School
![Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage | SpringerLink Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11239-021-02495-3/MediaObjects/11239_2021_2495_Fig2_HTML.png)
Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage | SpringerLink
![Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial - The Lancet Neurology Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2053239570/2060116756/gr1.gif)